1-stearoyl-2-<(5'Z,8'Z,11'Z,14'Z)-hydroxy-5',8',11',14'-icosatetraenoyl>-sn-glycero-3-phosphoserine | 132014-80-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 甘油磷脂
• 英文名称: 1-stearoyl-2-<(5'Z,8'Z,11'Z,14'Z)-hydroxy-5',8',11',14'-icosatetraenoyl>-sn-glycero-3-phosphoserine
• 英文别名: 4,6,9-Trioxa-5-phosphanonacosa-14,17,20,23-tetraenoic acid, 2-amino-5-hydroxy-10-oxo-8-[[(1-oxooctadecyl)oxy]methyl]-, 5-oxide, (2S,8R,14Z,17Z,20Z,23Z)-；(2S)-2-azaniumyl-3-[hydroxy-[(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy-3-octadecanoyloxypropoxy]phosphoryl]oxypropanoate
• CAS: 132014-80-3
• 化学式: C₄₄H₇₈NO₁₀P
• 分子量: 812.078
• InChiKey: SVOUGFFDROZBJI-DNALCEECSA-N

物化性质

• 沸点：
  832.0±75.0 °C(Predicted)
• 密度：
  1.055±0.06 g/cm3(Predicted)
• 物理描述：
  Solid
• 碰撞截面：
  287.88 Ų [M+H]+ [CCS Type: TIMS, Method: single field calibrated]

计算性质

• 辛醇/水分配系数(LogP)：
  10.1
• 重原子数：
  56
• 可旋转键数：
  42
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  172
• 氢给体数：
  3
• 氢受体数：
  11

反应信息

• 作为产物：
  描述：

  L-丝氨酸 、 L-α-磷脂酰胆碱-β-花生四烯酰-γ-硬脂酰 生成 1-stearoyl-2-<(5'Z,8'Z,11'Z,14'Z)-hydroxy-5',8',11',14'-icosatetraenoyl>-sn-glycero-3-phosphoserine
  参考文献：
  名称：

  Baba, Naomichi; Aoshi, Akihiro; Shigeta, Yasutami, Bioscience, Biotechnology and Biochemistry, 1994, vol. 58, # 10, p. 1927 - 1928

  摘要：

  DOI：

文献信息

• Novel neutral (bio)material
  申请人：Centre National de la Recherche Scientifique (CNRS)

  公开号：EP2444464A1

  公开（公告）日：2012-04-25

  The instant invention concerns - a method for preparing a material comprising the following steps of a) treating the support to obtain a layer having SiH function, b) grafting the SiH layer obtained in step a) with an alkene and a catalyst for covalently bonding the alkene to the coating, said alkene being non-terminal and/or having an hydrophilic part, and c) recovering a material comprising a support coated with a chain covalently grafted with Si-C bonds, - a material comprising a support, optionally comprising a polyhydrosiloxane layer, on which surface is covalently bonded a grafted chain, wherein the covalent bonding between the support and/or the polyhydrosiloxane and the chain is an Si-C bond, and the grafted chain is bonded through a non-terminal carbon, through more than one covalent bond and/or the chain is having at least one hydrophilic part, and - devices comprising such material.

  本发明涉及 - 一种制备材料的方法，包括以下步骤 a) 处理支持物以获得具有 SiH 功能的层；b) 将步骤 a) 中获得的 SiH 层与烯烃和催化剂接枝，以将烯烃共价键合到涂层上，所述烯烃为非末端烯烃和/或具有亲水部分；以及 c) 回收一种材料，该材料包括涂有共价键合的 Si-C 键接枝链的支持物、 - 一种材料，包括支撑体，可选择包括聚氢硅氧烷层，在支撑体表面共价键合了一条接枝链，其中支撑体和/或聚氢硅氧烷与链之间的共价键合是 Si-C 键，接枝链通过非末端碳键、通过一个以上的共价键和/或链具有至少一个亲水部分键合，以及 - 包括这种材料的装置。
• Compositions and methods for enhancing contrast in imaging
  申请人：Marval Biosciences, Inc.

  公开号：EP2578237A1

  公开（公告）日：2013-04-10

  Example compositions of liposomes with hydrophilic polymers on their surface, and containing relatively high concentrations of contrast- enhancing agents for computed tomography are provided. Example pharmaceutical compositions of such liposomes, when administered to a subject, provide for increased contrast of extended duration, as measured by computed tomography, in the bloodstream and other tissues of the subject. Also provided are example methods for making liposomes containing high concentrations of contrast-enhancing agents, and example methods for using the compositions.

  本发明提供了一些脂质体组合物实例，这些脂质体表面具有亲水性聚合物，并含有相对高浓度的计算机断层扫描造影剂。这种脂质体的药物组合物范例在给受试者用药时，可使受试者血液和其他组织中的对比度增加，持续时间延长，如计算机断层扫描所测。此外，还提供了制造含有高浓度造影剂的脂质体的示例方法，以及使用这些组合物的示例方法。
• FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND POLYPEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS
  申请人：Children's Hospital Medical Center

  公开号：EP3357490A1

  公开（公告）日：2018-08-08

  The present invention includes pharmaceutical and/or imaging agents and methods for delivering the agent(s) within and/or through the dermal, mucosal and other cellular membranes. The agents can include a fusogenic protein. This technology can be used for applications in which the objective is delivery of active agent within and/or beneath biological membranes and/or across the blood-brain barrier and neuronal membranes.

  本发明包括药物和/或成像制剂以及在皮肤、粘膜和其他细胞膜内和/或通过皮肤、粘膜和其他细胞膜输送制剂的方法。这些制剂可包括致熔蛋白。该技术可用于在生物膜内和/或生物膜下和/或穿过血脑屏障和神经元膜输送活性剂的应用。
• Liposomal formulation of nonglycosidic ceramides and uses thereof
  申请人：LUDWIG INSTITUTE FOR CANCER RESEARCH LTD.

  公开号：US10039715B2

  公开（公告）日：2018-08-07

  The invention provides liposomes containing nonglycosidic ceramides within their bilayers, and compositions thereof. These liposomes activate murine iNKT cells and induce dendritic cell (DC) maturation, both in vitro and in vivo at an efficacy that is comparable to their corresponding soluble nonglycosidic ceramides. Also provided are methods for treating diseases using the liposomes and compositions of the invention.

  本发明提供了在其双层内含有非糖苷类神经酰胺的脂质体及其组合物。这些脂质体可在体外和体内激活小鼠 iNKT 细胞并诱导树突状细胞（DC）成熟，其功效与相应的可溶性非糖苷神经酰胺相当。此外，还提供了使用本发明脂质体和组合物治疗疾病的方法。
• COMPOSITIONS COMPRISING FUSOGENIC PROTEINS OR POLYPEPTIDES DERIVED FROM PROSAPOSIN FOR APPLICATION IN TRANSMEMBRANE DRUG DELIVERY SYSTEMS
  申请人：Children's Hospital Medical Center

  公开号：EP2020988A2

  公开（公告）日：2009-02-11